Systemic inflammation promotes the release of fibrinogen, which promotes tumor cell proliferation and metastasis by participating in extracellular matrix formation and inducing epithelial–mesenchymal transition via the p-AKT/p-mTOR pathway and IL-6 synthesis (26–28). This evidence concerns the gene MTOR and neoplasm.